Annual accounts
Full accounts
31/10/2026Filing deadline
- Next accounts made up to
- 30/04/2026
- Last accounts made up to
- 30/04/2025
Reference data exactly as held at Companies House.
The 4 most recent documents filed at Companies House.
Termination of appointment of Christopher Stephen Dancer as a director on 2026-06-23
Cessation of Carmen Lewis as a person with significant control on 2016-08-01
Cessation of Gary Stephen Lewis as a person with significant control on 2016-08-01
Notification of A1 Pharmaceuticals Holding Limited as a person with significant control on 2025-12-12
What Pre-Score will tell you

The two filings Companies House requires every year, and where each one stands against its deadline today.
Full accounts
31/10/2026Filing deadline
Confirms the registry record is up to date
02/08/2027Filing deadline
The latest figures A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
2024: £16.37M
Total Assets
2024: £21.50M
Cash in Bank
2024: £3.83M
Total Liabilities
2024: £4.66M
Employees
2024: 50
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Cash in bank moved furthest, up 103.74% on 2024. See the full financial analysis for A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY.
The full financial record
Four ways through A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 52 | +2 |
| 2024 | 50 | -2 |
| 2023 | 52 | +16 |
| 2022 | 36 | 0 |
| 2021 | 36 | – |
Reported employee count increased from 36 in 2021 to 52 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 01/08/2019–Present | 3 | |
| Director | 01/08/2019–Present | 4 | |
| Nominee Director | 24/02/1992–04/03/1992 | 120 | |
| Director | 28/09/2022–23/06/2026 | 2 | |
| Director | 01/05/1995–13/11/2001 | 0 | |
| Nominee Secretary | 24/02/1992–04/03/1992 | 276 |
Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 01/08/2016–01/08/2016 | 17 | |
| 01/08/2016–01/08/2016 | 9 | |
| 01/08/2016–Present | 17 | |
| 01/08/2016–Present | 9 | |
| 12/12/2025–Present | 0 |
Every document on the Companies House record, newest first.
Termination of appointment of Christopher Stephen Dancer as a director on 2026-06-23
Cessation of Carmen Lewis as a person with significant control on 2016-08-01
Cessation of Gary Stephen Lewis as a person with significant control on 2016-08-01
Notification of A1 Pharmaceuticals Holding Limited as a person with significant control on 2025-12-12
Change of details for Mr Gary Stephen Lewis as a person with significant control on 2025-11-04
Director's details changed for Mrs Carmen Lewis on 2025-11-04
Director's details changed for Mr Henry Thomas John Lewis on 2025-11-04
Secretary's details changed for Mrs Carmen Lewis on 2025-11-04
Director's details changed for Mr Gary Stephen Lewis on 2025-11-04
Director's details changed for Mr Thomas William Lewis on 2025-11-04
Change of details for Mrs Carmen Lewis as a person with significant control on 2025-11-04
Full accounts made up to 2025-04-30
Showing 12 of 139 filings
See when the next accounts and confirmation statement are due
3 UK companies are similar to A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY, sharing the same company status (Active), the same industry sector and activity group (Wholesale of pharmaceutical goods) and a comparable number of employees. The 3 closest matches are shown below to help you compare competitors and industry peers.
Silverpoint, Moor Street, Bury BL9 5AQ
Lion Court, 25 Procter Street, Holborn, London WC1V 6NY
Easter Queenslie Industrial Est, Glasgow, G33 4TP
A short description of the company, written from its Companies House record.
A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY is a public limited company registered in the United Kingdom, based in Unit 20 & 21 Easter Industrial, Park, Ferry Lane South, Rainham, Essex RM13 9BP. Companies House classifies its business as Wholesale of pharmaceutical goods. It has been on the register for 34 years 7 months.
The register currently records it as active. Its 2025 accounts report net assets of £16.36M and 52 employees.
Answered from this company's own registry record and filed figures.
Companies House records A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY under one registered business activity: Wholesale of pharmaceutical goods (46.46 - SIC 2007).
A1 PHARMACEUTICALS PUBLIC LIMITED COMPANY is recorded as active on the Companies House register, and has been on it since 24/02/1992.
The most recent accounts Okredo holds cover 2025 and report net assets of £16.36M, total assets of £25.37M, cash in bank of £7.80M and total liabilities of £8.53M.
The most recent document on the record is dated 07/08/2026: Termination of appointment of Christopher Stephen Dancer as a director on 2026-06-23, 1 month ago.
On the current registry record, accounts are due by 31/10/2026 and the next confirmation statement is due by 02/08/2027.
Companies House lists 6 officers (2 currently in post) and 5 people with significant control (3 current).